Native Americans,
Intellectual Property,
Government
Feb. 28, 2018
Patent office ruling against Allergan, tribe may have sweeping implications
The Patent Trial and Appeal Board has ruled that sovereign immunity does not apply to patents involved in inter partes review, a decision which experts say will curtail further deals between Native American tribes and companies.
The Patent Trial and Appeal Board has ruled that sovereign immunity does not apply to patents involved in inter partes review, a decision which experts say will curtail further deals between Native American tribes and companies.
In the decision last Friday, the U.S. Patent and Trademark Office's appeal board denied a motion to dismiss filed by the Saint Regis Mohawk Tribe regarding litigation brought by Mylan Pharmaceuticals Inc., ...
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In